F

FGEN

Fibrogen Inc

0.44

0.01+2.86%
After Hours: 0.4400  +0.0007  +0.16%19:58 03/14 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE0.4210/0.4271
TODAY RANGE0.4210-0.4651
VOL1.22M
MARKET CAP44.27M
52 WEEK RANGE0.1800-2.800
AVG VOL (3M)3.56M
% TURNOVER1.21%
TURNOVER--
P/E (TTM)-0.3574
% RANGE10.04%
EPS(TTM)-1.2292
P/E(FORWARD)-0.5936
P/B-0.1817
BVPS-2.4181
DIVIDEND--
P/S0.2937
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP43.88M
SHARES OUTSTANDING100.77M
NEXT EARNINGS--
FREE FLOAT99.88M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Latest
Popular
Same Industry
Name/Symbol
Change%
Price

F

Fibrogen Inc

FGEN

+2.86%
0.4393

R

Regeneron Pharmaceuticals

REGN

-2.02%
666.87

E

Entero Therapeutics

ENTO

+2.12%
0.4820

B

BIONTECH

BNTX

+2.06%
99.47

U

United Therapeutics Corp.

UTHR

+0.61%
307.24

S

Siga Technologie

SIGA

+2.39%
5.58

V

Vertex Pharmaceuticals Inc

VRTX

+0.37%
504.77

M

Moderna

MRNA

+0.93%
34.62

C

Charles Riv Labs Intl Inc

CRL

+2.46%
171.04

M

Medpace Holdings

MEDP

+2.21%
324.95

T

Talphera Inc

TLPH

-0.89%
0.5600

I

ICON PLC

ICLR

+3.15%
184.58

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

+2.07%
185.19

M

MOLECULAR PARTNERS AG

MOLN

-1.37%
4.33

A

Arcturus Therape

ARCT

+1.30%
14.08

G

Gilead Sciences Inc

GILD

-1.00%
111.44

P

PRA Health

PRAH

--
165.21

I

Incyte Corp

INCY

+0.22%
67.86

A

Aptevo Therapeutics Inc

APVO

+1.26%
2.41

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.